These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 33008435)

  • 1. Challenging behavior in mucopolysaccharidoses types I-III and day-to-day coping strategies: a cross sectional explorative study.
    Hoffmann F; Hoffmann S; Kunzmann K; Ries M
    Orphanet J Rare Dis; 2020 Oct; 15(1):275. PubMed ID: 33008435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluating strategies to manage and endure challenging behaviors in mucopolysaccharidoses.
    Grant N
    Orphanet J Rare Dis; 2021 Apr; 16(1):165. PubMed ID: 33832528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Challenging symptoms in children with rare life-limiting conditions: findings from a prospective diary and interview study with families.
    Malcolm C; Hain R; Gibson F; Adams S; Anderson G; Forbat L
    Acta Paediatr; 2012 Sep; 101(9):985-92. PubMed ID: 22452449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IMPACT study: measuring the impact of caregiving on families and healthcare professionals of children and adults living with mucopolysaccharidoses in Ireland.
    Somanadhan S; Bristow H; Crushell E; Pastores G; Nicholson E; Kroll T; Larkin PJ; Brinkley A
    Ther Adv Rare Dis; 2021; 2():26330040211020764. PubMed ID: 37181103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of growth dynamics in different types of MPS: an attempt to explain the causes.
    Różdżyńska-Świątkowska A; Zielińska A; Tylki-Szymańska A
    Orphanet J Rare Dis; 2022 Sep; 17(1):339. PubMed ID: 36064607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parents' experiences of living with, and caring for children, adolescents and young adults with Mucopolysaccharidosis (MPS).
    Somanadhan S; Larkin PJ
    Orphanet J Rare Dis; 2016 Oct; 11(1):138. PubMed ID: 27724940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Parental social support, coping strategies, resilience factors, stress, anxiety and depression levels in parents of children with MPS III (Sanfilippo syndrome) or children with intellectual disabilities (ID).
    Grant S; Cross E; Wraith JE; Jones S; Mahon L; Lomax M; Bigger B; Hare D
    J Inherit Metab Dis; 2013 Mar; 36(2):281-91. PubMed ID: 23151683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mental retardation in mucopolysaccharidoses correlates with high molecular weight urinary heparan sulphate derived glucosamine.
    Coppa GV; Gabrielli O; Zampini L; Maccari F; Mantovani V; Galeazzi T; Santoro L; Padella L; Marchesiello RL; Galeotti F; Volpi N
    Metab Brain Dis; 2015 Dec; 30(6):1343-8. PubMed ID: 26016623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cannabidiol (Epidyolex®) for severe behavioral manifestations in patients with tuberous sclerosis complex, mucopolysaccharidosis type III and fragile X syndrome: protocol for a series of randomized, placebo-controlled N-of-1 trials.
    Müller AR; den Hollander B; van de Ven PM; Roes KCB; Geertjens L; Bruining H; van Karnebeek CDM; Jansen FE; de Wit MCY; Ten Hoopen LW; Rietman AB; Dierckx B; Wijburg FA; Boot E; Brands MMG; van Eeghen AM
    BMC Psychiatry; 2024 Jan; 24(1):23. PubMed ID: 38177999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence of the mucopolysaccharidoses in Northern Ireland.
    Nelson J
    Hum Genet; 1997 Dec; 101(3):355-8. PubMed ID: 9439667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estimated birth prevalence of mucopolysaccharidoses in Brazil.
    Federhen A; Pasqualim G; de Freitas TF; Gonzalez EA; Trapp F; Matte U; Giugliani R
    Am J Med Genet A; 2020 Mar; 182(3):469-483. PubMed ID: 31926052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The mucopolysaccharidoses: characterization by cranial MR imaging.
    Lee C; Dineen TE; Brack M; Kirsch JE; Runge VM
    AJNR Am J Neuroradiol; 1993; 14(6):1285-92. PubMed ID: 8279321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of pulmonary function impairments in patients with mucopolysaccharidoses--changes with age and treatment.
    Lin SP; Shih SC; Chuang CK; Lee KS; Chen MR; Niu DM; Chiu PC; Lin SJ; Lin HY
    Pediatr Pulmonol; 2014 Mar; 49(3):277-84. PubMed ID: 23401495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prenatal diagnosis of mucopolysaccharidoses (MPS): the first Egyptian experience.
    Aboul Nasr A; Fateen E
    Bratisl Lek Listy; 2004; 105(9):310-4. PubMed ID: 15633892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiology of mucopolysaccharidoses.
    Khan SA; Peracha H; Ballhausen D; Wiesbauer A; Rohrbach M; Gautschi M; Mason RW; Giugliani R; Suzuki Y; Orii KE; Orii T; Tomatsu S
    Mol Genet Metab; 2017 Jul; 121(3):227-240. PubMed ID: 28595941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heparan sulfate and dermatan sulfate derived disaccharides are sensitive markers for newborn screening for mucopolysaccharidoses types I, II and III.
    de Ruijter J; de Ru MH; Wagemans T; Ijlst L; Lund AM; Orchard PJ; Schaefer GB; Wijburg FA; van Vlies N
    Mol Genet Metab; 2012 Dec; 107(4):705-10. PubMed ID: 23084433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mucopolysaccharidoses and the eye.
    Ashworth JL; Biswas S; Wraith E; Lloyd IC
    Surv Ophthalmol; 2006; 51(1):1-17. PubMed ID: 16414358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cognitive endpoints for therapy development for neuronopathic mucopolysaccharidoses: Results of a consensus procedure.
    van der Lee JH; Morton J; Adams HR; Clarke L; Ebbink BJ; Escolar ML; Giugliani R; Harmatz P; Hogan M; Jones S; Kearney S; Muenzer J; Rust S; Semrud-Clikeman M; Wijburg FA; Yu ZF; Janzen D; Shapiro E
    Mol Genet Metab; 2017 Jun; 121(2):70-79. PubMed ID: 28501294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psychobehavioral factors and family functioning in mucopolysaccharidosis: preliminary studies.
    do Valle DA; Bara TDS; Furlin V; Santos MLSF; Cordeiro ML
    Front Public Health; 2024; 12():1305878. PubMed ID: 38327584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bony changes in common mucopolysaccharidoses.
    Chen SJ; Li YW; Wang TR; Hsu JC
    Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi; 1996; 37(3):178-84. PubMed ID: 8755171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.